Abstract
Cancer is one of the most fatal diseases next only to cardiovascular diseases spread all around the globe, and it is the third most fatal disease in India. Environmental factors such as chemicals, UV light, tobacco products, X-rays, viruses, and disturbance in oncogenes are the factors which induce mutations that are inheritable and result in cancer. PDT comprises of three essential components: photosensitizer (PS), light, and oxygen. Oxygen in the form of reactive oxygen species can be toxic and may lead to cell death via necrosis or apoptosis. PDT is a two-stage procedure. Administration of a light-sensitive PS is followed by irradiation of tumor loci with a light of appropriate wavelength. This chapter describes about oncogenes and role of photodynamic therapy in treatment of oncogenes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stern RS (2010) Prevalence of a history of skin cancer in 2007: results of an incidence-based model. Arch Dermatol 146(3):279–282
Calzavara-Pinton PG, Venturini M, Sala R (2007) Photodynamic therapy: update 2006. Part 1: photochemistry and photobiology. J Eur Acad Dermatol Venereol 21:293–302
Dougherty TJ, Gomer CJ, Henderson BW et al (1998) Photodynamic therapy. J Natl Cancer Inst 90(12):889–905
Allison RR, Mang TS, Wilson BD (1998) Photodynamic therapy for the treatment of nonmelanomatous cutaneous malignancies. Semin Cutan Med Surg 17(2):153–163
Bernstein ZP, Wilson BD, Oseroff AR et al (1999) Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi’s sarcoma. AIDS 13(13):1697–1704
Allison R, Mang T, Hewson G et al (2001) Photodynamic therapy for chest wall progression from breast carcinoma is an underutilized treatment modality. Cancer 91(1):1–8
Nielsen TO, Friis-Hansen L, Poulsen SS, Federspiel B, Sorensen BS (2014) Expression of the EGF family in gastric cancer: downregulation of HER4 and its activating ligand NRG4. PLoS One 9(4):e94606
Lindahl P, Johansson BR, Leveen P, Betsholtz C (1997) Science 277:242–245
Broek D et al (1987) The S. cerevisiae CDC25 gene product regulates the RAS/adenylate cyclase pathway. Cell 48:789–799
Land H, Parada LF, Weinberg RA (1983) Cellular oncogenes and multi-step carcinogenesis. Science 222:771–778
Parsons SJ, Parsons JT (2004) Src family kinases, key regulators of signal transduction. Oncogene 23:7906–7909. https://doi.org/10.1038/sj.onc.120816
Cheng LC, Tavazoie M, Doetsch F (2005) Stem cells: from epigenetics to microRNAs. Neuron 46:363–367
O’Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435:839–843
Borrello MG, Degl’innocenti D, Pierotti MA (2008) Inflammation and cancer: the oncogene-driven connection. Cancer Lett 267(2):262–270 [PubMed: 18502035]
Deindl S, Hwang WL, Hota SK, Blosser TR, Prasad P, Bartholomew B, Zhuang X (2013) ISWI remodelers slide nucleosomes with coordinated multi-base-pair entry steps and single-base-pair exit steps. Cell 152:442–452
Keyes WM, Pecoraro M, Aranda V, Lindahl EV, Li W, Vogel H, Guo X, Garcia EL, Michurina VT, Enikolopov G, Muthuswamy KS, Mills AA (2011) Np63a is an oncogene that targets chromatin remodeler Lsh to drive skin stem cell proliferation and tumorigenesis. Cell Stem Cell 8:164–176
Jenuwein T, Allis CD (2001) Translating the histone code. Science 293:1074–1080
Davies H et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949–954
Rushdi A, Nishikura K, Erikson J, Watt R, Rovera G, Croce CM (1983) Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. Science 222:390–393
Lusser A, Kadonaga JT (2003) Chromatin remodeling by ATP dependent molecular machines. Bioessays 25:1192–1200
Dueñas CV, Camarero IR, Cobaleda C, GarcÃa IS (2013) Function of oncogenes in cancer development: a changing paradigm. https://doi.org/10.1038/emboj.2013.97
Heldin CH, Westermark B (1999) Mechanism of action and in vivo role of platelet derived growth factor. Physiol Rev 79:1283–1316
Shaulian E, Karin M (2001) AP-1 in cell proliferation and survival. Oncogene 20:2390–2400
Croce CM (2008) Oncogenes and cancer. N Engl J Med 358:502–511
Bizouarn F (2014) Clinical applications using digital PCR. Methods Mol Biol 1160:189–214. https://doi.org/10.1007/978-1-4939-0733-5_16
Takamizawa J, Konish H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64:3753–3756
Sparmann A, Bar-Sagi D (2004) Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6(5):447–458 [PubMed: 15542429]
Oskarsson T, Trumpp A (2005) The Myc trilogy: lord of RNA polymerases. Nat Cell Biol 7:215–217
Grosjean P, Wagnieres G, Fontolliet C (1998) Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with photofrin II. Br J Cancer 77(11):1989–1995
Varmus H (1988) Retroviruses. Science 240:1427–1435
Fischle W, Wang Y, Allis CD (2003) Histone and chromatin cross-talk. Curr Opin Cell Biol 15:172–183 (36, 63, 142)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Agnihotry, S., Anas, M., Srivastav, A.K., Chopra, D., Upadhayay, J., Mujtaba, S.F. (2018). Role of Photodynamic Therapy in Cancer Treatment. In: Ray, R., Haldar, C., Dwivedi, A., Agarwal, N., Singh, J. (eds) Photocarcinogenesis & Photoprotection. Springer, Singapore. https://doi.org/10.1007/978-981-10-5493-8_14
Download citation
DOI: https://doi.org/10.1007/978-981-10-5493-8_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-5492-1
Online ISBN: 978-981-10-5493-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)